8-bromo cyclic adenosine monophosphate has been researched along with Fetal Growth Restriction in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Aharon, A; Al-Dabet, MM; Brenner, B; Fahlbusch, FB; Gadi, I; Hoffmann, J; Huebner, H; Isermann, B; Kohli, S; Lochmann, F; Löttge, M; Manoharan, J; Markmeyer, P; Ruebner, M; Shahzad, K; Zenclussen, AC | 1 |
1 other study(ies) available for 8-bromo cyclic adenosine monophosphate and Fetal Growth Restriction
Article | Year |
---|---|
p45 NF-E2 regulates syncytiotrophoblast differentiation by post-translational GCM1 modifications in human intrauterine growth restriction.
Topics: 8-Bromo Cyclic Adenosine Monophosphate; Acetylation; Animals; Apoptosis; Caspase 3; Cell Differentiation; DNA-Binding Proteins; Female; Fetal Growth Retardation; Humans; Mice; NF-E2 Transcription Factor, p45 Subunit; Nuclear Proteins; Pregnancy; Protein Processing, Post-Translational; Sumoylation; Transcription Factors; Trophoblasts | 2017 |